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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in Indonesia with 
over 13.000 new cases reported yearly, especially in the male. The TNF-α serum is reported as a new biomarker 
to predict bone invasion, post-therapy distant metastasis, and poor life sustainability in NPC. 
Objective: To identify the expression of TNF-α in regards to clinical stage of NPC. 
Method: This is an analytic study with 126 NPC samples of patients in Haji Adam Malik General Hospital. 
Result: NPC mostly found in age group 41-60 years (57.1%), male (71.4%), non-keratinizing SCC (79.4%), 
and stage IV group (54.8%). In immunohistochemistry evaluation, most of TNF-α overexpressed in non-
keratinizing SCC(68.0%), T3-T4 (50.8%), N2-N3 (62.7%) and clinical stage III-IV (69.9%). Spearman's test 
for categorical correlation yield a p-value of <0,001. 
Conclusion: There is a significant correlation between TNF-α expression and the stage of NPC. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma that 
grows on the lateral wall surface of nasopharynx [1, 2]. In Asia, especially 
China, NPC is in the 11th most common malignancy with an average 
incidence of nearly 25 cases per 100,000 [3, 4]. In Indonesia, it is reported 
more than 13,000 new cases yearly, especially in men, and associated with 
a high mortality rate [5-7]. 
Cytokines play an important role in the pathogenesis and maintenance 
of cancer in different ways which include TNF-α, TRAIL, IL-6, IL-10, IL-
12, IL-17 dan IL-23 [8]. TNF-α as a main pro-inflammatory cytokine is 
capable as an endogenous tumor promotor in bridging inflammation and 
carcinogenesis. New studies have shown the role of TNF-α in all 
carcinogenesis aspects such as cellular transformation, proliferation, 
invasion, angiogenesis, and metastasis [9]. 
The TNF-α serum is reported as a new biomarker to predict bone 
invasion, post-therapy distant metastasis, and poor life sustainability in NPC 
shows that TNF-α has biological significance in NPC [10-12].  
The signal pathway and transcription factor activated by TNF-α is 
considered important in the invasion and metastasis of cancer cells. Cancer 
cells are more dependent on the transcription factor compared to normal cells. 
The development of cancer cells inhibited and apoptosis is promoted through 
the inhibition of transcription factor and targeted signal pathway [13]. 
Considering the importance of TNF-α, the correlation of TNF-α expression 
to a clinical stadium of NPC patients is studied.  
2. MATERIAL AND METHODS 
The research was conducted from July to October 2017 in Adam Malik 
General Hospital, Medan, recruiting 126 samples of patients diagnosed with 
NPC based on history taking, physical examination, and histopathological 
biopsy in the period of 2015-2016. 
The inclusion criteria include patients diagnosed with NPC based on 
histopathological reports and was not received radiotherapy, chemotherapy, 
or a combination of both. By using the sampling formula, a minimal of 68 
patients are required for the research. The samples were collected using non-
probability consecutive sampling. The tissues were examined using 
immunohistochemistry under the fluorescent micro-scope evaluating the 
immunoreaction of TNF-α antibody. The results were evaluated based on 
the immunoreactivity score (≥4 is considered positive or overexpressed 
TNF- α) [14]. All data is presented in the table.  
Statistical package for social sciences (SPSS, version 11.5) was used to 
process the data. The correlation was measured using Spearman’s test.. A p-value 
less than 0.05 denoted the presence of a statistically significant difference. 
3. RESULT 
This study involved 126 samples with the highest frequency of patients 
found in the age group 41-60 years (57.1%). Regards to gender, the male 
group is the largest population of NPC patients with 90 samples (71.4%). 
The non-keratinizing squamous cell carcinoma (79.4%), and stage IV group 
(54.8%) is the most frequent regarding the histopathology characteristic. In 
immunohistochemistry evaluation, most of TNF-α overexpressed in non-
keratinizing squamous cell carcinoma (64.3%), T3-T4 primary tumor size 
(50.8%), neck nodes enlargement in the N2-N3 group (62.7%) and clinical 
stage in the III-IV group (69.9%). 
Correlation analysis using Spearman's test for categorical correlation 
yield p-value of <0,001, which indicates that there is a statistically 
significant correlation of clinical staging and the expression of TNF-α. 
Graphic 1. Frequency of Age, Sex, Histophatology, Primary Tumor (T), 
Nodes (S), and Clinical Staging results based on TNF-α expression. 
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4. DISCUSSION 
In this study, the largest group in nasopharyngeal carcinoma is in the age 
group of 41-60 years (57.1%). Similar to Adham (2012) in her study, the peak 
of the most NPC patients found at 40-49 years old. This happened because of 
the DNA repair mechanism function and the immune system has been 
decreased as it undergoes mutation at the age of more than 40 years [15]. 
In our study, we found a similar predominance, with 71.4% male and 
28.6% female cases yielding a 2.5:1 ratio. The male: female ratio was 
relatively stable over the years. Cao's (2011) study also found the incidence 
rate of NPC in men is higher than in women, with a ratio of 2-3:1. The 
exposure to environmental pollution from occupation and lifestyle caused 
males got a higher ratio than females diagnosed with NPC  [16]. 
In our study, non-keratinizing squamous cell carcinoma (79,4%) was 
the most common form of NPC, consistent with studies done in other high-
risk countries. More than 90% of NPC in the endemic area is non-
keratinizing squamous cell carcinoma  [5]. 
Tumor necrosis factor-alpha (TNF-α) is a kind of proinflammatory 
cytokines that mainly secreted by tumor cells and macrophages. TNF-α can 
not only take part in the mechanisms of apoptosis induction but also 
accelerate tumor growth in the process of tumor progression. And increasing 
evidence showed that TNF-α participated in many key processes of tumor 
progression including activation of the cancer gene, DNA damage, and 
tumor metastasis. High expression of TNF-α is closely related to tumor 
recurrence and lymph node metastasis [9]. In this study, we found TNF-α 
overexpression is most common in T3 primary tumors (30.2%). In regional 
metastasis, TNF-α overexpression was found most frequently in N3 lymph 
node (45.3%), and the lowest in N0 (7,1%). Elevated TNF-α expression was 
most common in stage IV (70%) and the highest TNF-α expression was 
found in non-keratinizing squamous cell carcinoma type (64.3%). 
TNF- α could increase the invasive nature of certain cancer types. This is 
due to induction on MMP2, 3, 9 and 12 or through α2β1 integrin. TNF-a can 
induce resistency o chemotherapy and destruct DNA and inhibit DNA repairment 
by increasing Nitric Oxide (NO) activity. Tumor remodeling due to fibroblast and 
macrofage activity, tumor cell motility, tumor invasion through induction of 
matrix metalloproteinases (MMPs) is also influenced by TNF- α. 
The result of this study showed that there is a significant correlation 
between the NPC clinical stage and the expression of TNF-α. Jin et al. 
(2017) reported a significant reduction of TNF-α expression after treatment 
of NPC, indicating that TNF-α expression may be used for clinical staging 
of NPC [17]. Andersson et al. (2014) also found that the upregulation of 
CRP and TNF-α in the NPC patient plasma was significantly related to 
shorter patient survival [18, 19]. 
5. CONCLUSION 
Our study suggested there is a significant relationship between TNF-α 
expression and NPC clinical stage. Therefore, a further study with larger 
samples is warranted, which could contribute to fully understand the 
association of the TNF-α and NPC, and to established a new approach in 
screening and surveillance of NPC using TNF-α. 
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